98319-24-5,
Dihydroproscar,
Dihydrofinasteride,
Dihydro Finasteride,
3-Oxo-4-aza-5-alpha-androstane-17-beta-N-t-butylcarboxamide,
(4AR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide,
3-oxo-4-aza-5a-androstane-17beta-(n-t-butylcarboxamide),
N-t-Butyl-3-oxo-4-aza-5alpha-androst-17beta-carboxamide,
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,8,9,9b,10,11-tetradecahydroindeno[5,4-f]quinoline-1-carboxamide,
Finasteride Impurity A,
PubChem20704,
1,2-Dihydrofinasteride,
3-Oxo-4-aza-5a-androstane-17b-(N-tert-butylcarboxamide),
N-t-butyl-4-aza-5-alpha-Androsta-3-one-17beta-Carboxamide,
3-oxo-4-aza-5a-androstane-17-beta-(n-tert-butylcarboxamide),
n-(1,1-dimethylethyl)-3-oxo-4-aza-5a-andro-stane-17b-carboxamide,
SCHEMBL4019990,
CHEMBL2298592,
DTXSID40432068,
ZOIUUCNFVDJSJK-WSBQPABSSA-N,
4a,6a,11a-trimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
EBD13047,
EX-A1946,
ZINC5921125,
MFCD00214352,
AKOS025310135,
ACN-043353,
CHM0025166,
NCGC00485347-01,
(2R,3R,4bS,6aS,7S,9aS,9bS)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
AK326242,
AS-35368,
BC201593,
SC-17251,
AX8035545,
A-2007,
319D245,
A845839,
C-21229,
3-Oxo-4-aza-5|A-androstane-17|A-(N-t-butylcarboxamide),
Finasteride Impurity A; Dihydro Finasteride; Dihydroproscar,
3-Oxo-4-aza-5-alpha-androstane-17-belta-N-t-butylcarboxamide,
3-OXO-4-AZA-5-ALPHA-ANDROSTANE-17-BETA-N-T-BUTYLCA,
3-Oxo-4-aza-5A-androstane-17-beta-(N-tert- butylcarboxamide),
3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide),
N-(tert-Butyl)-3-oxo-4-aza-5|A-androstane-17|A-carboxamide,
(5|A,17|A)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrostane-17-carboxamide,
3-Oxo-4-aza-5|A-androstan-17|A-carboxylic acid N-(tert-butyl)amide,
3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide), >=90%, powder,
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxidanylidene-1,2,3,3a,3b,4,5,5a,6,8,9,9b,10,11-tetradecahydroindeno[5,4-f]quinoline-1-carboxamide,
(2r,3r,4bs,6as,7s,9as,9bs)-4a,6a-dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic ac,
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide,
[4aR-(4a|A,4b|A,6a|A,7|A,9a|A,9b|A,11a|A)]-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide,
1H-Indeno[5,4-f]quinoline-7-carboxamide,N-(1,1-dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-,(4aR,4bS,6aS,7S,9aS,9bS,11aR)-,
N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide (Dihydrofinasteride),
CB11414,
CID9864387,
CS-O-05487,
CID 9864387,
N-tert-butyl-3-oxo-4-aza-5?-androst-17?-carboxamide,
F9:3-Oxo-4-aza-5a-androstane-17b-(N-tert-butylcarboxamide),
n-(1,1-dimethyl)-3-oxo-4-aza-5a-andro-stane-17b-carboxamide,
3-Oxo-4-aza-5alpha-androstane-17beta-(N-t-butylcarboxamide)/ Dihydroproscar/17|A-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one,